The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neuropharmacology

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NEUROPHARM.2005.09.006PMID 16288930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoamine neurons in aging and Alzheimer's disease

  2005cited by this paper
• The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).

  2004cited by this paper
• Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP

  2004cited by this paper
• BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders.

  2004cited by this paper
• Depression: a case of neuronal life and death?

  2004cited by this paper
• Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.

  2004cited by this paper
• Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.

  2004cited by this paper
• Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis.

  2003cited by this paper
• Neuronal and Astroglial Responses to the Serotonin and Norepinephrine Neurotoxin: 1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine

  2003cited by this paper
• The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity.

  2003cited by this paper
• Site-Selective Neurotoxicity

  2002cited by this paper
• The astrocyte response to neural injury: a review and reconsideration of key features

  2002cited by this paper
• Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity?

  2002cited by this paper
• Hippocampal brain amines in methotrexate-induced learning and memory deficit.

  2002cited by this paper
• 2′-NH2-MPTP [1-Methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine] Depletes Serotonin and Norepinephrine in Rats: A Comparison with 2′-CH3-MPTP [1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine]

  2002cited by this paper
• Postsynaptic Induction of BDNF-Mediated Long-Term Potentiation

  2002cited by this paper
• GAP-43 Is Critical for Normal Development of the Serotonergic Innervation in Forebrain

  2002cited by this paper
• Compensatory responses in the aging hippocampal serotonergic system following neurodegenerative injury with 5,7‐dihydroxytryptamine

  2001cited by this paper
• The selective vulnerability of brainstem nuclei to Alzheimer's disease

  2001cited by this paper
• BDNF Promotes the Regenerative Sprouting, But Not Survival, of Injured Serotonergic Axons in the Adult Rat Brain

  2000cited by this paper
• Brain‐derived neurotrophic factor and neurotrophin‐3 levels in Alzheimer's disease brains

  2000cited by this paper
• Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.

  1999cited by this paper
• Effects of 5,7‐dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: Relationship to behavior

  1999cited by this paper
• Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain.

  1999cited by this paper
• Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

  1998cited by this paper
• Endogenous BDNF protein is increased in adult rat hippocampus after a kainic acid induced excitotoxic insult but exogenous BDNF is not neuroprotective.

  1998cited by this paper
• Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.

  1996cited by this paper
• Neurochemical studies of Alzheimer's disease.

  1996cited by this paper
• Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain

  1995cited by this paper
• Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.

  1994cited by this paper
• MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels

  1994cited by this paper
• Sustained Depletion of Cortical and Hippocampal Serotonin and Norepinephrine but Not Striatal Dopamine by 1‐Methyl‐4‐(2′‐Aminophenyl)‐1,2,3,6‐Tetrahydropyridine (2′‐NH2‐MPTP): A Comparative Study with 2′‐CH3‐MPTP and MPTP

  1993cited by this paper
• Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.

  1993cited by this paper
• 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.

  1993cited by this paper
• Age‐related Cognitive Deficits in Rats Are Associated with a Combined Loss of Cholinergic and Serotonergic Functions a

  1993cited by this paper
• Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical Involvement

  1992cited by this paper
• Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+.

  1992cited by this paper
• Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

  1992cited by this paper
• Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity.

  1992cited by this paper
• Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5‐HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives

  1991cited by this paper
• Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker.

  1991cited by this paper
• Anatomic evidence for a neurotoxic effect of (+/-)-fenfluramine upon serotonergic projections in the rat.

  1990cited by this paper
• Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's dementia.

  1990cited by this paper
• Amelioration of spatial memory impairment by intrahippocampal grafts of mixed septal and raphe tissue in rats with combined cholinergic and serotonergic denervation of the forebrain.

  1990cited by this paper
• Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission.

  1989cited by this paper
• Monoaminergic neurotransmitters in Alzheimer's disease. An HPLC study comparing presenile familial and sporadic senile cases.

  1989cited by this paper
• Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine.

  1989cited by this paper
• Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

  1988cited by this paper
• Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA).

  1988cited by this paper
• Dopamine and Serotonin Systems in Human and Rodent Brain: Effects of Age and Neurodegenerative Disease

  1987cited by this paper
• The serotoninergic innervation of cerebral cortex: Different classes of axon terminals arise from dorsal and median raphe nuclei

  1987cited by this paper
• The aging of the brain

  1982cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Non-transgenic rodent models of Alzheimer’s disease for preclinical research: a review

  2025cites this paper
• MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions

  2017cites this paper
• 20-NH2-MPTP: A Serotonin and Norepinephrine Neurotoxin

  2014cites this paper
• Omega‐3 fatty acid eicospentaenoic acid attenuates MPP+‐induced neurodegeneration in fully differentiated human SH‐SY5Y and primary mesencephalic cells

  2013cites this paper
• Neonatal serotonin (5-HT) depletion does not affect spatial learning and memory in rats

  2012cites this paper
• Neonatal serotonin ( 5-HT ) depletion does not affect spatial learning and memory in rats

  2012cites this paper
• Native serotonin membrane receptors recognize 5-hydroxytryptophan-functionalized substrates: enabling small-molecule recognition.

  2010cites this paper
• Dissociation between Serotonin Neurotoxicity and Brain-Derived Neurotrophic Factor Induction following Neonatal MDMA Exposure in Rats

  2009cites this paper
• Effects of prodynorphin deletion on striatal dopamine in mice during normal aging and in response to MPTP.

  2009cites this paper
• Biospecific Recognition of Tethered Small Molecules Diluted in Self‐Assembled Monolayers

  2008cites this paper
• Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory.

  2008cites this paper
• AGING AND THE DYNORPHINERGIC SYSTEM: EVALUATION OF MEMORY AND MOTOR SYSTEMS IN PRODYNORPHIN KNOCKOUT MICE

  2007cites this paper
• Reduced brain‐derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice

  2007cites this paper
• Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.

  2006cites this paper